Delivering on the Promise of Regenerative Medicine

Harbor MedTech, Inc. is a fully integrated, commercial-stage regenerative medicine company with a patented technology. Our BriDGE® platform creates a stabilized collagen matrix that prevents our products from degrading; thus allowing them to heal in as few as one application.

Our first BriDGE® technology product, Architect®, is FDA cleared and CE marked for healing chronic skin wounds. Architect® upregulates the patient’s own immune response to accelerate healing, reduce biofilm formation, and can treat patients in as few as one application.

Leveraging the BriDGE® platform, Harbor MedTech has a robust pipeline, including products that meet significant unmet needs in breast reconstruction, hernia repair, Achilles tendon and rotator cuff repair as well as many other surgical applications.

Jerry Mezger

President & CEO

Read Extended Bio

Keith Myers

Chief Technology Officer

Read Extended Bio

Jim Klingler

Chief Financial Officer

Read Extended Bio

Jon Zalk

Chief Commercial Officer

Read Extended Bio

Sandra Berriman

VP Clinical Affairs

Read Extended Bio

Recent News Releases

What’s new in the Harbor MedTech world?

Contact Us for More Information

Click Here